Search Results

There are 9585 results for: content related to: Sequential chemoimmunotherapy of fludarabine, mitoxantrone, and cyclophosphamide induction followed by alemtuzumab consolidation is effective in T-cell prolymphocytic leukemia

  1. Alemtuzumab for patients with chronic lymphocytic leukaemia

    Intervention Review

    The Cochrane Library

    Nicole Skoetz, Kathrin Bauer, Thomas Elter, Ina Monsef, Verena Roloff, Michael Hallek and Andreas Engert

    Published Online : 15 FEB 2012, DOI: 10.1002/14651858.CD008078.pub2

  2. Alemtuzumab (MabCampath)

    Handbook of Therapeutic Antibodies

    Thomas Elter, Andreas Engert, Michael Hallek, Pages: 733–777, 2008

    Published Online : 1 FEB 2008, DOI: 10.1002/9783527619740.ch28

  3. Treatment of chronic lymphoid leukemias with monoclonal antibodies: current place and perspectives

    Drug Development Research

    Volume 69, Issue 7, November 2008, Pages: 373–387, Tadeusz Robak

    Version of Record online : 23 DEC 2008, DOI: 10.1002/ddr.20269

  4. T-cell prolymphocytic leukemia: A rare disease in an elderly female

    Journal of the American Academy of Nurse Practitioners

    Volume 22, Issue 12, December 2010, Pages: 648–653, Linda Madaris

    Version of Record online : 5 NOV 2010, DOI: 10.1111/j.1745-7599.2010.00566.x

  5. You have free access to this content
    Guidelines for the management of mature T-cell and NK-cell neoplasms (excluding cutaneous T-cell lymphoma)

    British Journal of Haematology

    Volume 153, Issue 4, May 2011, Pages: 451–485, Claire E. Dearden, Rod Johnson, Ruth Pettengell, Stephen Devereux, Kate Cwynarski, Sean Whittaker, Andrew McMillan and British Committee for Standards in Haematology

    Version of Record online : 11 APR 2011, DOI: 10.1111/j.1365-2141.2011.08651.x

  6. You have free access to this content
    Prolymphocytic leukaemia of B- and T-cell subtype: a state-of-the-art paper

    European Journal of Haematology

    Volume 80, Issue 6, June 2008, Pages: 469–476, M. Dungarwalla, E. Matutes and C. E. Dearden

    Version of Record online : 10 MAR 2008, DOI: 10.1111/j.1600-0609.2008.01069.x

  7. Treatment of patients with advanced mycosis fungoides and Sézary syndrome with alemtuzumab

    European Journal of Haematology

    Volume 71, Issue 4, October 2003, Pages: 250–256, G. A. Kennedy, J. F. Seymour, M. Wolf, H. Januszewicz, J. Davison, C. McCormack, G. Ryan and H. M. Prince

    Version of Record online : 1 SEP 2003, DOI: 10.1034/j.1600-0609.2003.00143.x

  8. Therapeutic Approaches to the Mature T-Cell Lymphoproliferative Leukemias

    Leukemias: Principles and Practice of Therapy

    Nnenna Osuji, Claire Dearden, Pages: 348–361, 2011

    Published Online : 4 JAN 2011, DOI: 10.1002/9781444327359.ch29

  9. You have free access to this content
    Phase II study of alemtuzumab in chronic lymphoproliferative disorders

    Cancer

    Volume 98, Issue 4, 15 August 2003, Pages: 773–778, Alessandra Ferrajoli, Susan M. O'Brien, Jorge E. Cortes, Francis J. Giles, Deborah A. Thomas, Stefan Faderl, Razelle Kurzrock, Susan Lerner, Dimitrios P. Kontoyiannis and Michael J. Keating

    Version of Record online : 26 JUN 2003, DOI: 10.1002/cncr.11551

  10. You have free access to this content
    Stem cell transplantation after alemtuzumab in T-cell prolymphocytic leukaemia results in longer survival than after alemtuzumab alone: a multicentre retrospective study

    British Journal of Haematology

    Volume 149, Issue 6, June 2010, Pages: 907–910, Biju Krishnan, Monica Else, Geir E. Tjonnfjord, Bruno Cazin, Dennis Carney, John Carter, Nicolas Ketterer, Daniel Catovsky, Mark Ethell, Estella Matutes and Claire E. Dearden

    Version of Record online : 1 MAR 2010, DOI: 10.1111/j.1365-2141.2010.08134.x

  11. You have free access to this content
    Rediscovering alemtuzumab: current and emerging therapeutic roles

    British Journal of Haematology

    Volume 144, Issue 6, March 2009, Pages: 818–831, John G. Gribben and Michael Hallek

    Version of Record online : 12 JAN 2009, DOI: 10.1111/j.1365-2141.2008.07557.x

  12. You have free access to this content
    Alemtuzumab for multiple sclerosis

    Intervention Review

    The Cochrane Library

    Rachel Riera, Gustavo JM Porfírio and Maria R Torloni

    Published Online : 15 APR 2016, DOI: 10.1002/14651858.CD011203.pub2

  13. The successful use of alemtuzumab for treatment of steroid-refractory acute graft-versus-host disease in pediatric patients

    Pediatric Transplantation

    Volume 18, Issue 1, February 2014, Pages: 94–102, Pooja Khandelwal, Julia Lawrence, Alexandra H. Filipovich, Stella M. Davies, Jacob J. Bleesing, Michael B. Jordan, Parinda Mehta, Sonata Jodele, Michael S. Grimley, Ashish Kumar, Kasiani Myers and Rebecca A. Marsh

    Version of Record online : 30 OCT 2013, DOI: 10.1111/petr.12183

  14. A pediatric case of T-cell prolymphocytic leukemia

    Pediatric Blood & Cancer

    Volume 62, Issue 6, June 2015, Pages: 1061–1062, Bryan Mitton, Steven Coutre, Jennifer Willert, Krysta Schlis, Matthew Porteus, Sandhya Kharbanda and Rajni Agarwal-Hashmi

    Version of Record online : 21 NOV 2014, DOI: 10.1002/pbc.25336

  15. You have free access to this content
    Investigation of Lymphocyte Depletion and Repopulation Using Alemtuzumab (Campath-1H) in Cynomolgus Monkeys

    American Journal of Transplantation

    Volume 10, Issue 4, April 2010, Pages: 773–783, D. J. Van Der Windt, C. Smetanka, C. Macedo, J. He, R. Lakomy, R. Bottino, B. Ekser, G. J. Echeverri, D. Metes, J. N. M. Ijzermans, M. Trucco, D. K. C. Cooper and F. G. Lakkis

    Version of Record online : 20 MAR 2010, DOI: 10.1111/j.1600-6143.2010.03050.x

  16. Alemtuzumab versus interferon beta 1a for relapsing-remitting multiple sclerosis

    Intervention Review

    The Cochrane Library

    Jian Zhang, Shengliang Shi, Yueling Zhang, Jiefeng Luo, Yousheng Xiao, Lian Meng and Xiaobo Yang

    Published Online : 27 NOV 2017, DOI: 10.1002/14651858.CD010968.pub2

  17. Primary refractory T-cell prolymphocytic leukaemia treated with daily administration of Alemtuzumab plus high-dose methylprednisolone

    European Journal of Haematology

    Volume 92, Issue 4, April 2014, Pages: 360–361, Edward Renaudon-Smith, John G. Gribben and Samir G. Agrawal

    Version of Record online : 28 JAN 2014, DOI: 10.1111/ejh.12248

  18. You have free access to this content
    Chronic lymphocytic leukemia: 2015 Update on diagnosis, risk stratification, and treatment

    American Journal of Hematology

    Volume 90, Issue 5, May 2015, Pages: 446–460, Michael Hallek

    Version of Record online : 23 APR 2015, DOI: 10.1002/ajh.23979

  19. Allogeneic hematopoietic stem cell transplantation for T-prolymphocytic leukemia: a report from the French society for stem cell transplantation (SFGM-TC)

    European Journal of Haematology

    Volume 94, Issue 3, March 2015, Pages: 265–269, Thierry Guillaume, Yves Beguin, Reza Tabrizi, Stéphanie Nguyen, Didier Blaise, Eric Deconinck, Rabah Redjoul, Jérôme Cornillon, Gaëlle Guillerm, Nathalie Contentin, Anne Sirvent, Pascal Turlure, Alexandra Salmon, Anne Huynh, Sylvie François, Régis Peffault de Latour, Ibrahim Yakoub-Agha and Mohamad Mohty

    Version of Record online : 13 SEP 2014, DOI: 10.1111/ejh.12430

  20. FDA Drug Approval Summary: Alemtuzumab as Single-Agent Treatment for B-Cell Chronic Lymphocytic Leukemia

    The Oncologist

    Volume 13, Issue 2, February 2008, Pages: 167–174, Suzanne Demko, Jeffrey Summers, Patricia Keegan and Richard Pazdur

    Version of Record online : 1 FEB 2008, DOI: 10.1634/theoncologist.2007-0218